Literature DB >> 11402379

Clinical application of the multifocal VEPs.

Y Betsuin1, Y Mashima, H Ohde, R Inoue, Y Oguchi.   

Abstract

PURPOSE: To determine whether visual field defects can be detected by the multifocal VEP technique.
METHODS: Multifocal VEPs were elicited by a pseudorandom binary m-sequence stimulus (VERIS II). The stimulus was a dartboard-like pattern of 61 sectors, and the luminance of each sector alternated between white and black. The stimulus area subtended approximately 25 degrees. Each recording was divided into 8 equal segments, and the total recording time was about 4 min. Multifocal VEPs were recorded from 25 normal subjects and six patients with visual field loss. The responses summed within 4 quadrants were used in the analysis and were compared with the visual fields obtained by perimetry.
RESULTS: In six perimetrically-documented visual field defects, the responses summed over each quadrant of the field were reduced in the corresponding affected quadrants. In addition, recovery of the visual field loss following treatment was accompanied by a recovery of the responses.
CONCLUSIONS: Multifocal VEPs summed within four quadrants can be used for an objective evaluation of the visual fields. The testing can be obtained in 4 min with no pain or discomfort to the patient.

Entities:  

Mesh:

Year:  2001        PMID: 11402379     DOI: 10.1076/ceyr.22.1.54.6982

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  12 in total

1.  Multifocal examination techniques in malingering: case report of a patient with monocular vertical hemianopia.

Authors:  Anja M Palmowski; Andreas Fischer; Klaus W Ruprecht
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-12-06       Impact factor: 3.117

2.  The effect of fixation instability on the multifocal VEP.

Authors:  Michael Menz; Erich Sutter; Momoyo Menz
Journal:  Doc Ophthalmol       Date:  2004-09       Impact factor: 2.379

3.  Case report of multiple sclerosis in which visual function was evaluated using multifocal visual evoked potentials.

Authors:  Eiichi Yukawa; Yeong-Jin Kim; Tetsuo Ueda; Yoshiaki Hara
Journal:  Jpn J Ophthalmol       Date:  2007-04-06       Impact factor: 2.447

4.  Investigating the effects of glaucomatous damage on the multifocal visual evoked potential parameters.

Authors:  Amir Danyaei; Ali Kasiri; Seyed Mahmoud Latifi; Parvin Armiun; Mohammad Javad Tahmasebi
Journal:  Int Ophthalmol       Date:  2019-06-21       Impact factor: 2.031

5.  Objective perimetry using the multifocal visual evoked potential in central visual pathway lesions.

Authors:  A I Klistorner; S L Graham; J Grigg; C Balachandran
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

6.  Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.

Authors:  Manju Jayaraman; S Ambika; Rashmin Anilkumar Gandhi; Shikha Rajesh Bassi; Priya Ravi; Parveen Sen
Journal:  Doc Ophthalmol       Date:  2010-09-04       Impact factor: 2.379

7.  IJO in it's 60 th year.

Authors:  Sundaram Natarajan
Journal:  Indian J Ophthalmol       Date:  2013-02       Impact factor: 1.848

8.  Acute Visual Field Defect following Vitrectomy Determined to Originate from Optic Nerve by Electrophysiological Tests.

Authors:  Atsuro Uchida; Kei Shinoda; Celso Soiti Matsumoto; Miho Kawai; Sayaka Kawai; Hisao Ohde; Yoko Ozawa; Susumu Ishida; Makoto Inoue; Atsushi Mizota; Kazuo Tsubota
Journal:  Case Rep Ophthalmol       Date:  2012-09-20

9.  Multifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.

Authors:  Marcella Nebbioso; Robert D Steigerwalt; Josè Pecori-Giraldi; Enzo M Vingolo
Journal:  Indian J Ophthalmol       Date:  2013-02       Impact factor: 1.848

10.  Multifocal Visual Evoked Potentials (mfVEP) in Diabetic Patients with and without Polyneuropathy.

Authors:  Monica Lövestam-Adrian; Lotta Gränse; Gert Andersson; Sten Andreasson
Journal:  Open Ophthalmol J       Date:  2012-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.